These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 2140372)
1. A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder. Diniz JB; Shavitt RG; Fossaluza V; Koran L; Pereira CA; Miguel EC J Clin Psychopharmacol; 2011 Dec; 31(6):763-8. PubMed ID: 22020357 [TBL] [Abstract][Full Text] [Related]
2. The benefits of clomipramine-fluoxetine combination in obsessive compulsive disorder. Browne M; Horn E; Jones TT Can J Psychiatry; 1993 May; 38(4):242-3. PubMed ID: 8518974 [TBL] [Abstract][Full Text] [Related]
3. Obsessive-compulsive disorder in children and adolescents. A review of the literature. Thomsen PH Eur Child Adolesc Psychiatry; 1994 Jul; 3(3):138-158. PubMed ID: 29871422 [TBL] [Abstract][Full Text] [Related]
5. Fluoxetine: a review on evidence based medicine. Rossi A; Barraco A; Donda P Ann Gen Hosp Psychiatry; 2004 Feb; 3(1):2. PubMed ID: 14962351 [TBL] [Abstract][Full Text] [Related]
6. Age differences in the sensitivity to clomipramine in an animal model of obsessive-compulsive disorder. Fernández-Guasti A; Ulloa RE; Nicolini H Psychopharmacology (Berl); 2003 Mar; 166(3):195-201. PubMed ID: 12589517 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic approaches to the treatment of refractory obsessive-compulsive disorder. Kochan LD; Qureshi AI; Fallon BA Curr Psychiatry Rep; 2000 Aug; 2(4):327-34. PubMed ID: 11122977 [TBL] [Abstract][Full Text] [Related]
8. A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder. Carpenter LL; McDougle CJ; Epperson CN; Price LH Drug Saf; 1996 Aug; 15(2):116-34. PubMed ID: 8884163 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area. Prisco S; Esposito E Br J Pharmacol; 1995 Sep; 116(2):1923-31. PubMed ID: 8528581 [TBL] [Abstract][Full Text] [Related]
10. Clomipramine versus fluoxetine in obsessive-compulsive disorder: a retrospective comparison of side effects and efficacy. Jenike MA; Baer L; Greist JH J Clin Psychopharmacol; 1990 Apr; 10(2):122-4. PubMed ID: 2140372 [TBL] [Abstract][Full Text] [Related]
11. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results. Pigott TA; Pato MT; Bernstein SE; Grover GN; Hill JL; Tolliver TJ; Murphy DL Arch Gen Psychiatry; 1990 Oct; 47(10):926-32. PubMed ID: 2222131 [TBL] [Abstract][Full Text] [Related]
12. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination. Simeon JG; Thatte S; Wiggins D Psychopharmacol Bull; 1990; 26(3):285-90. PubMed ID: 2274627 [TBL] [Abstract][Full Text] [Related]
13. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder. López-Ibor JJ; Saiz J; Cottraux J; Note I; Viñas R; Bourgeois M; Hernández M; Gómez-Pérez JC Eur Neuropsychopharmacol; 1996 May; 6(2):111-8. PubMed ID: 8791036 [TBL] [Abstract][Full Text] [Related]
14. [Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine]. Volk S Fortschr Neurol Psychiatr; 1995 Jun; 63 Suppl 1():28-32. PubMed ID: 7635392 [No Abstract] [Full Text] [Related]